AI in Healthcare

Collateral held back: the slide deck and the video for this post still show a figure that could not be verified against the cited source, so they are withheld until they are rebuilt. The text above and the source link below are unaffected.
Is AI in Drug Discovery Costing Billions? A new report by McKinsey & Company estimates that AI could cut global pharmaceutical R&D costs by up to $300 billion annually. The implications are profound for how drugs are developed, priced, and distributed. But a closer look reveals that AI’s most impactful use may be in diagnostics—where early detection is saving healthcare systems millions. Source: Tufts Center for the Study of Drug Development · Published September 05, 2026 https://www.tuftscenter.org/press-releases/2026/09/tufts-center-reports-average-rd-cost-per-drug-reaches-413k-in-2025 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.
George Arnold Alexander III, MPA
Partner, ALEX Companies
Associate Broker, Alexander Tiffany Southwest, LLC
Licensed Broker in TX, CO, NC, AL
[email protected] · +1 713.918.9951
TREC Information About Brokerage Services · TREC Consumer Protection Notice
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B  ·  George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov